Equity Capital Markets
Our Equity Capital Markets team is experienced in the successful execution of all categories of private and public equity offerings
By connecting growth-oriented companies with a network of high-quality investors, we deliver compelling results for issuers of a variety of products.
- SPAC IPO
- Confidentially Marketed Public Offering (CMPO)
- Registered Direct (RD)
- Private Placement
- At-the-Market Offering (ATM)
- Convertible Bond
- Other hybrid solutions
Our relationships are based on a detailed understanding of our clients’ objectives. Our approach brings together the full capabilities of Cowen to meet their needs. Our mission is to provide a high-touch experience and be a trusted resource for all of our clients, across all stages of growth.
Uber Technologies, Inc. offers peer-to-peer ridesharing, ride service hailing, food delivery, and other transportation services via its mobile applications in over 785 metropolitan areas worldwide.
Twist is a leading and rapidly growing synthetic biology company that has developed a disruptive, scalable DNA synthesis platform targeted at diverse end markets.
Milestone Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing its Phase III product candidate, etripamil, for the treatment of cardiovascular indications.
Grant MillerManaging Director and Head, Capital Markets Group646 562 1164
Michael CampbellManaging Director, Capital Markets415 646 7262
Jason FentonManaging Director and Head, Healthcare Capital Markets646 562 1294
Bill FollisManaging Director, Equity Capital Markets646 562 1237
Iain FranksManaging Director and Head, Convertible and Equity-Linked Products415 646 7266
Michael MurphyManaging Director, Equity Capital Markets646 562 1171
Chris WeekesManaging Director, Equity Capital Markets646 562 1133